GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

GSK has announced a 50/50 joint venture with leading Indian vaccines company, Biological E, for the early stage research and development of a six-in-one combination paediatric vaccine to help ...

Weber is currently President & General Manager at GSK Vaccines, CEO of GSK Biologicals SA in Belgium and member of the GSK global Corporate Executive Team. "We have extremely high expectations for ...

Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna A spokesperson for Massachusetts-based Moderna said the company was aware of the ...

Commercially available routine infant vaccination (Tritanrix-HB/Hib; GlaxoSmithKline Biologicals) against diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b (Hib ...

the Canadian Science Centre for Human and Animal Health and GSK Biologicals (Belgium). A microbiologist by training, Paul has specialised in a management systems approach to managing risk in ...